Skip to content
Sample Page
Author:
ExCellThera
Posted Date:
July 16, 2026
Zemcelpro® distribution agreement announced for Argentina, Hong Kong and Singapore
ExCellThera
July 16, 2026
Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Canada
ExCellThera
June 10, 2026
Zemcelpro® (dorocubicel) Positive Results in High- and Very High-Risk Blood Cancers to be Reported at the EBMT 2026 Annual Meeting
ExCellThera
March 10, 2026
